Target Product Profiles
The Strategic Blueprint Behind Every Successful Drug
Learn how the most successful biopharma teams use Target Product Profiles to accelerate development, align cross-functional teams, and bring breakthrough treatments to market with confidence.
Hundreds of promising drug candidates fail every year. Not because the science is weak. Because the strategy is unclear.
A Target Product Profile (TPP) is the strategic blueprint that guides every decision—from clinical trial design to market positioning to competitive strategy. It answers one critical question: What does this product need to become to deliver value for companies and patients?
Download our shareable one-page guide to the foundations, strategy, and real-world proof behind Target Product Profiles.
See More Target Product Profile Resources
Let's Get Started
Additional Target Product Profile Resources
We’ve helped emerging biotech teams evolve their TPPs from IND through Phase 3. We’ve facilitated big pharma workshops where preclinical, medical affairs, regulatory, commercial, and finance teams locked strategy together. We’ve helped companies reposition when the competitive landscape shifted overnight.
Explore our insights on Target Product Profiles and discover how a strong TPP could accelerate your path to market.
Understand the foundations, evolution, and cross-functional approach to building Target Product Profiles that actually drive results.
Explore real-world case studies showing how emerging biotech and pharma teams used Target Product Profiles to navigate development challenges.
Discover how we help teams navigate the full commercialization planning process from IND to launch.
Ready to Tackle Your Product Strategy?
If you’re developing a new treatment and want to discuss how a strong Target Product Profile could accelerate your path to market, let’s connect.
Stay Updated!
Connecting the Dots is our monthly newsletter for biopharma leaders exploring the realities of commercialization, sharing of best practices, and other musings.